Zacks Investment Research
07 Aug 2026, 00:31 UTC · 1h ago
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 00:31 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ICU Medical (ICUI) reported an EPS of $2.37 for the quarter ended June 2026, exceeding the Zacks Consensus Estimate of $1.91 by 24.08%. — A significant earnings beat typically drives immediate positive price action and suggests stronger-than-expected operational efficiency.
+0.60ICU Medical reported quarterly revenue of $547.88 million, representing a 2.33% surprise over the consensus estimate of $535.43 million. — While positive, the revenue surprise is modest compared to the earnings beat, suggesting steady but not explosive growth.
+0.30ICU Medical's revenue for the quarter ended June 2026 increased by 0.8% compared to the same period last year. — Flat year-over-year revenue growth indicates a stagnation in top-line expansion despite the earnings beat.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company reported revenue and EPS that both beat analyst expectations, with a significant EPS surprise of 24.08%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
37m ago
